全文获取类型
收费全文 | 2003篇 |
免费 | 110篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 72篇 |
妇产科学 | 23篇 |
基础医学 | 223篇 |
口腔科学 | 80篇 |
临床医学 | 168篇 |
内科学 | 522篇 |
皮肤病学 | 45篇 |
神经病学 | 80篇 |
特种医学 | 205篇 |
外国民族医学 | 1篇 |
外科学 | 198篇 |
综合类 | 39篇 |
预防医学 | 92篇 |
眼科学 | 10篇 |
药学 | 96篇 |
中国医学 | 5篇 |
肿瘤学 | 254篇 |
出版年
2023年 | 9篇 |
2022年 | 16篇 |
2021年 | 30篇 |
2020年 | 29篇 |
2019年 | 36篇 |
2018年 | 45篇 |
2017年 | 40篇 |
2016年 | 39篇 |
2015年 | 47篇 |
2014年 | 66篇 |
2013年 | 99篇 |
2012年 | 111篇 |
2011年 | 93篇 |
2010年 | 97篇 |
2009年 | 100篇 |
2008年 | 79篇 |
2007年 | 79篇 |
2006年 | 63篇 |
2005年 | 78篇 |
2004年 | 62篇 |
2003年 | 78篇 |
2002年 | 58篇 |
2001年 | 56篇 |
2000年 | 52篇 |
1999年 | 45篇 |
1998年 | 64篇 |
1997年 | 46篇 |
1996年 | 45篇 |
1995年 | 30篇 |
1994年 | 39篇 |
1993年 | 31篇 |
1992年 | 25篇 |
1991年 | 37篇 |
1990年 | 20篇 |
1989年 | 32篇 |
1988年 | 30篇 |
1987年 | 29篇 |
1986年 | 18篇 |
1985年 | 20篇 |
1984年 | 13篇 |
1983年 | 16篇 |
1982年 | 16篇 |
1981年 | 11篇 |
1980年 | 15篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 15篇 |
1976年 | 11篇 |
1975年 | 9篇 |
1966年 | 8篇 |
排序方式: 共有2131条查询结果,搜索用时 15 毫秒
51.
52.
53.
De Berardis G Pellegrini F Franciosi M Belfiglio M Di Nardo B Greenfield S Kaplan SH Rossi MC Sacco M Tognoni G Valentini M Nicolucci A;QuED 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2008,18(1):57-65
Background and aimIn the context of the QuED Study we assessed whether a quality of care summary score was able to predict the development of cardiovascular (CV) events in patients with type 2 diabetes.Methods and resultsThe score was calculated using process and intermediate outcome indicators (HbA1c, blood pressure, low-density lipoprotein cholesterol, microalbuminuria) and ranged from 0 to 40. Overall, 3235 patients were enrolled, of whom 492 developed a CV event after a median follow-up of 5 years. The incidence rate (per 1000 person-years) of CV events was 62.4 in patients with a score ≤10, 54.8 in those with a score between 15 and 20, and 39.8 in those with a score >20. In adjusted multilevel regression models, the risk to develop a CV event was 89% greater in patients with a score of ≤10 (rate ratio [RR] = 1.89; 95% confidence interval [CI] 1.43–2.50) and 43% higher in those with a score between 10 and 20 (RR = 1.43; 95% CI 1.14–1.79), as compared to those with a score >20. A difference between centers of 5 points in the mean quality score was associated with a difference of 16% in CV event risk (RR = 0.84; 95% CI 0.72–0.98).ConclusionOur study documented for the first time a close relationship between a score of quality of diabetes care and long-term outcomes. 相似文献
54.
Franciosi M Pellegrini F De Berardis G Belfiglio M Di Nardo B Greenfield S Kaplan SH Rossi MC Sacco M Tognoni G Valentini M Nicolucci A;Quality of Care Outcomes in Type Diabetes 《American heart journal》2005,149(1):104-111
Background
Clinical trials demonstrate significant benefit from cholesterol management for patients with type 2 diabetes. The aim of this work was to explore the correlates of lipid management in patients with type 2 diabetes, including the subjective beliefs of physicians, setting of care, and patient-related factors.Methods
This longitudinal outcomes research study involved 2359 patients with type 2 diabetes recruited by 111 general practitioners and 214 physicians practicing in diabetes clinics. Physicians' beliefs were assessed through a questionnaire administered when the study started in 1998. Main outcome measures were total cholesterol (TC) and LDL cholesterol (LDL-C) levels over 3 years and the proportion of patients treated with lipid-lowering drugs (LLDs).Results
Less than one-third of the physicians (27%) stated that they routinely started pharmacologic therapy for TC values ≥200 mg/dL (more aggressive), whereas 46% considered a TC level ≥240 mg/dL as the threshold for the initiation of treatment (less aggressive). During 3 years of observation, mean TC and LDL-C levels decreased from 215 ± 40 mg/dL to 203 ± 37 mg/dL and from 135 ± 36 mg/dL to 126 ± 35 mg/dL respectively, while the proportion of patients treated with LLDs increased from 13.2% to 24.6%; in particular, among individuals cared for by the more aggressive physicians, 30.0% were taking LLDs after 3 years, while only 17.7% of those followed by the less aggressive physicians and 18.1% of those followed by >1 physician were being treated with LLDs. Multilevel analysis showed that physicians' beliefs were an independent predictor of TC levels over the 3-year period. In patients treated with LLDs, TC levels decreased on average by 14%, and LDL-C levels decreased by 20%.Conclusion
Our data show that physicians' beliefs in more aggressive management strategies will result in better mean TC values over a 3-year period. 相似文献55.
56.
57.
Rashid Khan Ashwani K Singal Bhupinderjit S Anand 《World journal of gastroenterology : WJG》2014,20(34):11935-11938
Alcohol abuse and chronic hepatitis C virus(HCV)infection are two major causes of chronic liver disease in the United States.About 10%-15%of liver transplants performed in the United States are for patients with cirrhosis due to combined alcohol and HCV infection.Data on outcomes on graft and patient survival,HCV recurrence,and relapse of alcohol use comparing transplants in hepatitis C positive drinkers compared to alcohol abuse or hepatitis C alone are conflicting in the literature.Some studies report a slightly better overall outcome in patients who were transplanted for alcoholic cirrhosis vs those transplanted for HCV alone or for combined HCV and alcohol related cirrhosis.However,some other studies do not support these observations.However,most studies are limited to a retrospective design or small sample size.Larger prospective multicenter studies are needed to better define the outcomes in hepatitis C drinkers. 相似文献
58.
Hermine A van Duyvenvoorde Julian C Lui Sarina G Kant Wilma Oostdijk Antoinet CJ Gijsbers Mari?tte JV Hoffer Marcel Karperien Marie JE Walenkamp Cees Noordam Paul G Voorhoeve Verónica Mericq Alberto M Pereira Hedi L Claahsen-van de Grinten Sandy A van Gool Martijn H Breuning Monique Losekoot Jeffrey Baron Claudia AL Ruivenkamp Jan M Wit 《European journal of human genetics : EJHG》2014,22(5):602-609
Height is a highly heritable and classic polygenic trait. Recent genome-wide association studies (GWAS) have revealed that at least 180 genetic variants influence adult height. However, these variants explain only about 10% of the phenotypic variation in height. Genetic analysis of short individuals can lead to the discovery of novel rare gene defects with a large effect on growth. In an effort to identify novel genes associated with short stature, genome-wide analysis for copy number variants (CNVs), using single-nucleotide polymorphism arrays, in 162 patients (149 families) with short stature was performed. Segregation analysis was performed if possible, and genes in CNVs were compared with information from GWAS, gene expression in rodents'' growth plates and published information. CNVs were detected in 40 families. In six families, a known cause of short stature was found (SHOX deletion or duplication, IGF1R deletion), in two combined with a de novo potentially pathogenic CNV. Thirty-three families had one or more potentially pathogenic CNVs (n=40). In 24 of these families, segregation analysis could be performed, identifying three de novo CNVs and nine CNVs segregating with short stature. Four were located near loci associated with height in GWAS (ADAMTS17, TULP4, PRKG2/BMP3 and PAPPA). Besides six CNVs known to be causative for short stature, 40 CNVs with possible pathogenicity were identified. Segregation studies and bioinformatics analysis suggested various potential candidate genes. 相似文献
59.
60.
Gondim JO Avaca-Crusca JS Valentini SR Zanelli CF Spolidorio DM Giro EM 《International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children》2012,22(2):116-124
International Journal of Paediatric Dentistry 2012; 22: 116–124 Background. Intracanal medication is important for endodontic treatment success as it eliminates microorganisms that persist after biomechanical preparation. Aim. To evaluate the effect of two intracanal medications against Porphyromonas gingivalis and Enterococcus faecalis in the root canals of human primary teeth with necrotic pulp with and without furcal/periapical lesion, using quantitative real‐time polymerase chain reaction (qRT‐PCR). Design. Thirty‐two teeth with necrotic pulp were used. Twelve teeth did not present lesion, and 20 teeth presented radiographically visible furca/periapical lesion. Microbiological samples were collected after coronal access and biomechanical preparation. The teeth were medicated with calcium hydroxide pastes prepared with either polyethylene glycol or chlorhexidine. After 30 days, the medication was removed and a third collection was performed. Microbiological samples were processed using qRT‐PCR. Data were analysed by Wilcoxon and Mann–Whitney tests (α = 0.05). Results. There was no significant difference in the microbiota present in the primary teeth with and without furcal/periapical lesion. Biomechanical preparation was effective in reducing the number of microorganisms (P < 0.05). The intracanal medications had similar antibacterial activity. Conclusion. The association of chlorhexidine with calcium hydroxide did not increase the antibacterial activity of the intracanal medication in the treatment of primary teeth with necrotic pulp with and without furcal/periapical lesion. 相似文献